STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Aurora Cannabis Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Aurora Cannabis Inc. (ACB) has furnished a routine Form 6-K with the U.S. SEC dated 19 June 2025. The filing’s sole purpose is to transmit Exhibit 99.1, identified as a "News release dated June 19, 2025." No financial statements, operational metrics, or transactional details accompany the submission. The document simply confirms that the Company continues to report under Form 40-F and is signed by CEO Miguel Martin. Because the actual news release is not included in the provided content, investors receive no new quantitative or strategic information from this 6-K alone.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Filing only forwards a news release; no financial or strategic data, therefore neutral impact.

This Form 6-K functions as a cover sheet for Exhibit 99.1. In isolation, it adds no insight into Aurora Cannabis’s performance, liquidity, or outlook. Without the attachment, investors cannot assess whether the underlying news release is material. As such, the submission maintains compliance but has no discernible effect on valuation models or risk profiles.

TL;DR: Routine compliance filing; governance posture unchanged.

The document demonstrates timely SEC reporting and proper officer sign-off by CEO Miguel Martin, reflecting adherence to disclosure obligations. However, there are no governance changes, board actions, or regulatory issues noted. The impact on shareholder rights or oversight mechanisms is therefore neutral.

 

 

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File No. 001-38691

AURORA CANNABIS INC.
(Translation of registrant's name into English)

 

2207 90B St. SW
Edmonton, Alberta T6X 1V8
Canada

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  ☐ Form 40-F  ☒

 

 

 
 

 

 

 

SUBMITTED HEREWITH

 

Exhibits Description 
99.1   News release dated June 19, 2025

 

 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AURORA CANNABIS INC.

/s/ Miguel Martin

 


Miguel Martin
Chief Executive Officer

Date: June 19, 2025

FAQ

Why did Aurora Cannabis (ACB) file this Form 6-K?

To furnish Exhibit 99.1, a news release dated June 19 2025, as required for foreign private issuers.

Does the filing include any financial results or guidance for Aurora Cannabis?

No. No financial statements, earnings data, or guidance are contained in the provided filing.

Who signed the Form 6-K on behalf of Aurora Cannabis?

The filing is signed by Miguel Martin, Chief Executive Officer.

Is this filing under Form 20-F or Form 40-F?

The company indicates it files annual reports under Form 40-F.

What is Exhibit 99.1 mentioned in the filing?

Exhibit 99.1 is referenced as a news release dated June 19 2025; its contents are not included here.
Aurora Cannabis Inc

NASDAQ:ACB

ACB Rankings

ACB Latest News

ACB Latest SEC Filings

ACB Stock Data

246.67M
56.22M
14.97%
10.69%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Edmonton